Clinical trial
Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis
NCT00333385 · Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche, Other · Terminated
Key facts
| NCT number | NCT00333385 |
|---|---|
| Title | Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis |
| Lead sponsor | Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche, Other |
| Collaborators | Vaincre la Mucoviscidose GlaxoSmithKline Industry Baxter Healthcare Corporation Roche Pharma AG |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis, Pseudomonas Aeruginosa, Pulmonary Exacerbation |
| Intervention type | Drug |
| Interventions | ceftazidime |
| Enrollment | 120 |
| Start date | Oct 1, 2001 |
| Completion | Apr 1, 2004 |
| First posted | Jun 5, 2006 |
| Last update posted | Jun 5, 2006 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: